Mimedx (MDXG) EPS (Basic) (2016 - 2025)
Historic EPS (Basic) for Mimedx (MDXG) over the last 16 years, with Q3 2025 value amounting to $0.11.
- Mimedx's EPS (Basic) rose 12000.0% to $0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.28, marking a year-over-year decrease of 5483.87%. This contributed to the annual value of $0.29 for FY2024, which is 4047.07% down from last year.
- Per Mimedx's latest filing, its EPS (Basic) stood at $0.11 for Q3 2025, which was up 12000.0% from $0.07 recorded in Q2 2025.
- Mimedx's EPS (Basic)'s 5-year high stood at $0.39 during Q4 2023, with a 5-year trough of -$0.11 in Q1 2022.
- Over the past 5 years, Mimedx's median EPS (Basic) value was $0.05 (recorded in 2024), while the average stood at $0.02.
- In the last 5 years, Mimedx's EPS (Basic) crashed by 26666.67% in 2022 and then skyrocketed by 205000.0% in 2023.
- Mimedx's EPS (Basic) (Quarter) stood at -$0.02 in 2021, then changed by 0.0% to -$0.02 in 2022, then skyrocketed by 2050.0% to $0.39 in 2023, then tumbled by 87.02% to $0.05 in 2024, then surged by 117.37% to $0.11 in 2025.
- Its EPS (Basic) was $0.11 in Q3 2025, compared to $0.07 in Q2 2025 and $0.05 in Q1 2025.